entertainment -WSS

entertainment

author：leisure time 2025-09-30 00:50:04 - browse：6

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： U.K. considers world's first use of meningitis vaccine to address gonorrhea

WSS

Stroke deaths set to near 10 million globally by 2050

Why age limits for politicians are a terrible idea

FDA rejects Alnylam's heart disease treatment over insufficient data

Why age limits for politicians are a terrible idea

PBM reforms clear House panel

Hospitals look to new technology to keep health care workers safe

hotspot

entertainment

entertainment

Sports medicine is finally prioritizing gender equality

Astellas still sees hope in its gene therapy after four deaths

What does generative AI mean for health care? We asked experts

Was Amgen transparent enough on FDA's concern on cancer drug?

What does generative AI mean for health care? We asked experts

Senate panel eyes new effort on drug shortages

Supreme Court strikes down use of affirmative action

The future of health care in the House

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

focus

Weight loss drug costs may need more research, senator suggests

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Chan Zuckerberg Biohub Chicago to focus on inflammation

CRISPR pioneers react to Casgevy, first gene

Congress must reauthorize a committee to support older Americans

hotspot

focus

hotspot

leisure time